International Journal of High Risk Behaviors and Addiction

Published by: Kowsar

Developing a Brief Scale to Measure HIV Transmission Risk Among Injecting Drug Users

Armita Shahesmaeili 1 , 2 , Ali Akbar Haghdoost 2 and Hamid Soori 3 , *
Authors Information
1 Regional Knowledge Hub and WHO Collaborating Center for HIV Surveillance, Institute for Future Studies in Health, Kerman University of Medical Sciences, Kerman, IR Iran
2 Research Center for Modeling in Health, Institute for Future Studies in Health, Kerman University of Medical Sciences, Kerman, IR Iran
3 Safety Promotion and Injury Prevention Research Center, Shahid Beheshti University of Medical Sciences, Tehran, IR Iran
Article information
  • International Journal of High Risk Behaviors and Addiction: December 01, 2015, 4 (4); e26159
  • Published Online: December 12, 2015
  • Article Type: Research Article
  • Received: December 16, 2014
  • Accepted: February 3, 2015
  • DOI: 10.5812/ijhrba.26159

To Cite: Shahesmaeili A, Haghdoost A A, Soori H. Developing a Brief Scale to Measure HIV Transmission Risk Among Injecting Drug Users, Int J High Risk Behav Addict. 2015 ; 4(4):e26159. doi: 10.5812/ijhrba.26159.

Copyright © 2015, Zahedan University of Medical Sciences. This is an open-access article distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 International License ( which permits copy and redistribute the material just in noncommercial usages, provided the original work is properly cited.
1. Background
2. Objectives
3. Patients and Methods
4. Results
5. Discussion
  • 1. Harm Reduction International. . The global state of harm reduction 2012: towards an integrated response. 2012;
  • 2. World Health Organization . Surveillance of Populations at High Risk for HIV Transmission. 2007;
  • 3. UNODC . World drug report 2014. 2014;
  • 4. Mumtaz GR, Weiss HA, Thomas SL, Riome S, Setayesh H, Riedner G, et al. HIV among people who inject drugs in the Middle East and North Africa: systematic review and data synthesis. PLoS Med. 2014; 11(6)[DOI][PubMed]
  • 5. Degenhardt L, Mathers B, Vickerman P, Rhodes T, Latkin C, Hickman M. Prevention of HIV infection for people who inject drugs: why individual, structural, and combination approaches are needed. Lancet. 2010; 376(9737): 285-301[DOI][PubMed]
  • 6. Palmateer N, Kimber J, Hickman M, Hutchinson S, Rhodes T, Goldberg D. Evidence for the effectiveness of sterile injecting equipment provision in preventing hepatitis C and human immunodeficiency virus transmission among injecting drug users: a review of reviews. Addiction. 2010; 105(5): 844-59[DOI][PubMed]
  • 7. Golden RE, Collins C, Cunningham S, Newman EN, Card JJ. Overview of Structural Interventions to Decrease Injection Drug-Use Risk. Best Evidence Structural Interventions for HIV Prevention. 2013; : 41-121[DOI]
  • 8. Beyrer C, Malinowska-Sempruch K, Kamarulzaman A, Kazatchkine M, Sidibe M, Strathdee SA. Time to act: a call for comprehensive responses to HIV in people who use drugs. Lancet. 2010; 376(9740): 551-63[DOI][PubMed]
  • 9. Mathers BM, Degenhardt L, Ali H, Wiessing L, Hickman M, Mattick RP, et al. HIV prevention, treatment, and care services for people who inject drugs: a systematic review of global, regional, and national coverage. Lancet. 2010; 375(9719): 1014-28[DOI][PubMed]
  • 10. Valente TW. Network interventions. Science. 2012; 337(6090): 49-53[DOI][PubMed]
  • 11. Latkin CA. A personal network approach to AIDS prevention: an experimental peer group intervention for street-injecting drug users: the SAFE study. NIDA Res Monogr. 1995; 151: 181-95[PubMed]
  • 12. Strathdee SA, Hallett TB, Bobrova N, Rhodes T, Booth R, Abdool R, et al. HIV and risk environment for injecting drug users: the past, present, and future. Lancet. 2010; 376(9737): 268-84[DOI][PubMed]
  • 13. Suh T, Mandell W, Latkin C, Kim J. Social network characteristics and injecting HIV-risk behaviors among street injection drug users. Drug Alcohol Depend. 1997; 47(2): 137-43[PubMed]
  • 14. Fendrich M, Smith EJ, Pollack LM, Mackesy-Amiti ME. Measuring sexual risk for HIV: a Rasch scaling approach. Arch Sex Behav. 2009; 38(6): 922-35[DOI][PubMed]
  • 15. Reed SJ. A Study of the Validity of a Modified Ordinal Scale of HIV Transmission Risk Among Seropositive Men who Have Sex with Men 2012;
  • 16. Jemmott JB, Jemmott LS, Fong GT. Reductions in HIV risk-associated sexual behaviors among black male adolescents: effects of an AIDS prevention intervention. Am J Public Health. 1992; 82(3): 372-7[PubMed]
  • 17. Darke S, Hall W, Heather N, Ward J, Wodak A. The reliability and validity of a scale to measure HIV risk-taking behaviour among intravenous drug users. Aids. 1991; 5(2): 181-6[DOI]
  • 18. Dowling-Guyer S, Johnson ME, Fisher DG, Needle R, Watters J, Andersen M, et al. Reliability of drug users' self-reported HIV risk behaviors and validity of self-reported recent drug use. Assessment. 1994; 1(4): 383-92
  • 19. Dutta A, Wirtz AL, Baral S, Beyrer C, Cleghorn FR. Key harm reduction interventions and their impact on the reduction of risky behavior and HIV incidence among people who inject drugs in low-income and middle-income countries. Curr Opin HIV AIDS. 2012; 7(4): 362-8[DOI][PubMed]
  • 20. Fatseas M, Denis C, Serre F, Dubernet J, Daulouede JP, Auriacombe M. Change in HIV-HCV risk-taking behavior and seroprevalence among opiate users seeking treatment over an 11-year period and harm reduction policy. AIDS Behav. 2012; 16(7): 2082-90[DOI][PubMed]
  • 21. Benjamini Y. Simultaneous and selective inference: Current successes and future challenges. Biom J. 2010; 52(6): 708-21[DOI][PubMed]
  • 22. UNAIDS. . Guidelines on modeling the expected short-term distribution of new hiv infections by modes of transmission. 2012;
Creative Commons License Except where otherwise noted, this work is licensed under Creative Commons Attribution Non Commercial 4.0 International License .

Search Relations:



Create Citiation Alert
via Google Reader

Readers' Comments